The gut microbiota in adults with chronic intestinal failure
Clinical Nutrition · 2024-06 · 43 (6) · 1331-1342
DOI: 10.1016/j.clnu.2024.04.018 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Nutrition, 2024-06. Verfasst von Loris Pironi und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy; Centre for Chronic Intestinal Failure, IRCCS AOUBO, Bologna, Ital…. Hauptthemen laut MEDLINE: Gastrointestinal Microbiome, Feces, Short Bowel Syndrome. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 61 Literaturangaben.
Abstract (Originalsprache)
OBJECTIVE: Fecal microbiota was investigated in adult patients with chronic intestinal failure (CIF) due to short bowel syndrome (SBS) with jejunocolonic anastomosis (SBS-2). Few or no data are available on SBS with jejunostomy (SBS-1) and CIF due to intestinal dysmotility (DYS) or mucosal disease (MD). We profiled the fecal microbiota of various pathophysiological mechanisms of CIF. METHODS: Cross-sectional study on 61 adults with CIF (SBS-1 30, SBS-2 17, DYS 8, MD 6). Fecal samples were collected and profiled by 16S rRNA amplicon sequencing. Healthy controls (HC) were selected from pre-existing cohorts, matched with patients by sex and age. RESULTS: Compared to HC, SBS-1, SBS-2 and MD patients showed lower alpha diversity; no difference was found for DYS. In beta diversity analysis, SBS-1, SBS-2 and DYS groups segregated from HC and from each other. Taxonomically, the CIF groups differed from HC even at the phylum level. In particular, CIF patients' microbiota was dominated by Lactobacillaceae and Enterobacteriaceae, while depleted in typical health-associated taxa belonging to Lachnospiraceae and Ruminococcaceae. Notably, compositional peculiarities of the CIF groups emerged. Furthermore, in the SBS groups, the microbiota profile differed according to the amount of parenteral nutrition required and the duration of CIF. CONCLUSIONS: CIF patients showed marked intestinal dysbiosis with microbial signatures specific to the pathophysiological mechanism of CIF as well as to the severity and duration of SBS.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy; Centre for Chronic Intestinal Failure, IRCCS AOUBO, Bologna, Italy. Electronic address: loris.pironi@unibo.it.
- Microbiomics Unit, Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy.
- Centre for Chronic Intestinal Failure, IRCCS AOUBO, Bologna, Italy.
- Unit of Microbiome Science and Biotechnology, Department of Pharmacy and Biotechnology, University of Bologna, Bologna, Italy.
Zitieren
APA
Pironi, L., D'Amico, F., Guidetti, M., Brigidi, P., Sasdelli, A. S., & Turroni, S. (2024). The gut microbiota in adults with chronic intestinal failure. Clinical Nutrition, 43(6), 1331-1342. https://doi.org/10.1016/j.clnu.2024.04.018
Vancouver
Pironi L, D'Amico F, Guidetti M, Brigidi P, Sasdelli AS, Turroni S. The gut microbiota in adults with chronic intestinal failure. Clinical Nutrition. 2024;43(6):1331-1342. doi:10.1016/j.clnu.2024.04.018
BibTeX
@article{Pironi2024,
author = {Pironi, Loris and D'Amico, Federica and Guidetti, Mariacristina and Brigidi, Patrizia and Sasdelli, Anna Simona and Turroni, Silvia},
title = {The gut microbiota in adults with chronic intestinal failure},
journal = {Clinical Nutrition},
year = {2024},
volume = {43},
number = {6},
pages = {1331--1342},
doi = {10.1016/j.clnu.2024.04.018}
}
EUVIMED